Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
69
days
The effect of repeated administration of lumateperone on cytochrome P450 expression and activity in rat liver
Authors
Przemysław J. Danek; Renata Pukło; Władysława A. DanielShow moreShow less
Affiliations
1. Department of Pharmacokinetics and Drug Metabolism, Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, PolandShow moreShow less
86
days
DUSP6/MKP3 as an emerging therapeutic target in glioblastoma
Authors
Samantha Messina; Monica Rienzo; Erika Di ZazzoShow moreShow less
Affiliations
1. Department of Science, Roma Tre University, Rome, Italy; 2. Department of Environmental, Biological, and Pharmaceutical Sciences and Technologies, University of Campania “Luigi Vanvitelli”, Caserta, Italy; 3. Department of Medicine and Health Sciences “V. Tiberio”, University of Molise, Campobasso, ItalyShow moreShow less
183
days
Glycation stress in glioma: a metabolic vulnerability and therapeutic target
Authors
Sonia B. Umdor; Ellora SenShow moreShow less
Affiliations
1. National Brain Research Centre, Manesar, IndiaShow moreShow less
203
days
Adverse events during cystic fibrosis transmembrane conductance regulator modulator therapy in children with cystic fibrosis: an observational study
Authors
Marta Osińska; Beata Narożna; Ewa Sapiejka; Paulina Famulska; Katarzyna Tąpolska-Jóźwiak; Anna Steinert-Dymecki; Aleksandra Kozłowska; Maria Jóźwiak; Joanna Nowakowska-Lewicka; Agnieszka Bienert; Irena Wojsyk-BanaszakShow moreShow less
Affiliations
1. Department of Pediatrics and Cystic Fibrosis, Polanki Children’s Hospital, Gdańsk, Poland; 2. Department of Pulmonology, Pediatric Allergy and Clinical Immunology, Poznań University of Medical Sciences, Poznań, Poland; 3. Department of Psychiatry, Laboratory of Systems Psychopharmacology and Pharmacometrics, Poznań University of Medical Sciences, Poznań, PolandShow moreShow less
78
days
Nucleotide-binding oligomerization domain (NOD-), leucine-rich repeat (LRR-), and pyrin domain-containing protein 3 (NLRP3) inflammasome and snake venoms/toxins: mechanisms, pathophysiological relevance, and translational perspectives
Authors
Charles Nunes Boeno; Mauro Valentino Paloschi; Milena Daniela Souza Silva; Juliana Pavan ZulianiShow moreShow less
Affiliations
1. Laboratory of Cellular Immunology Applied to Health, Fundação Oswaldo Cruz, FIOCRUZ - Rondônia, Porto Velho, Brazil; 2. National Institute for Research on Infectious and Chronic Diseases of the Mucous Membranes and Skin (INCT Mucosas e Pele), Federal University of Minas Gerais, Belo Horizonte, Brazil; 3. Faculty of Health Sciences – Medicine, Federal University of Rondônia, UNIR, Porto Velho, BrazilShow moreShow less
36
days
Multi-target-directed drugs: new additions in 2025 and post-marketing safety surveillance of drugs marketed in 2022–2024
Authors
Piotr Ryszkiewicz; Marta Baranowska-Kuczko; Barbara Malinowska; Eberhard SchlickerShow moreShow less
Affiliations
1. Department of Experimental Physiology and Pathophysiology, Medical University of Białystok, Białystok, Poland; 2. Department of Experimental Physiology and Pathophysiology, Department of Clinical Pharmacy, Medical University of Białystok, Białystok, Poland; 3. Department of Pharmacology and Toxicology, University of Bonn, Bonn, GermanyShow moreShow less
FAQ
How long does Pharmacological Reports take to review a manuscript?
As of 2026-11-19, CrushSCI has 15 complete review records for Pharmacological Reports. The fastest paper went from submission to acceptance in 36 days (Multi-target-directed drugs: new additions in 2025 and post-marketing safety surveillance of drugs marketed in 2022–2024, received 2026-06-02, accepted 2026-07-08); the slowest took 253 days. The average is 116.7 days and the median is 114 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
